Summary As bioactive ingredients of functional foods, dietary fiber and wheat albumin (WA) are known to suppress hyperglycemia in patients with type 2 diabetes mellitus. The combined effects of these bioactive ingredients were examined using an animal model of type 2 diabetes mellitus. First, oral starch tolerance tests (OSTTs) with the simultaneous intake of a dietary fiber mixture (DF) and WA were performed as an acute study. Male GotoKakizaki rats received a soluble starch solution [700 mg/kg body weight (bw)] containing DF and/or WA (each 300 mg/kg bw). In these OSTTs, the combined intake of DF and WA suppressed hyperglycemia much more effectively than each separate intake. Second, in a chronic intake study, diets containing DF and/or WA were administered to male Zucker diabetic fatty rats over 84 d. The combined effects of DF and WA were not observed in glycosylated hemoglobin concentration levels or fasting blood glucose levels, but appeared as an improvement in liver lipid contents. Variations in the liver lipid contents were similarly reflected in those of the plasma lipid concentrations. In conclusion, this study found that the simultaneous intake of bioactive DF and WA improved the postprandial hyperglycemia and the chronic lipid metabolism disorders in rat models of type 2 diabetes mellitus. Key Words type 2 diabetes mellitus, dietary fiber, wheat albumin, combined effect, lipid metabolism disorder
In type 2 diabetes mellitus, postprandial hyperglycemia caused by a lack of prompt insulin secretion is closely associated with insulin resistance and thus hyperglycemia, which leads to a lipid metabolism disorder that results in arteriosclerosis (1) (2) (3) . Some dietary fiber, such as water-soluble dietary fiber, physically retards the absorption of glucide and suppresses postprandial hyperglycemia (4) . In Japan, therefore, the dietary fibers extracted mostly from various plants are used as functional ingredients of foods. On the other hand, wheat albumin (WA), based on the action of its principle component 0.19-albumin (termed by its electrophoretic mobility), inhibits mammalian amylase (5, 6) , delays glucide digestion in vivo, and suppresses postprandial hyperglycemia (7) . Thus, WA is widely distributed as a bioactive ingredient of food for specified health uses (FOSHU) in the market. Various consumers, intentionally or unintentionally take simultaneously more than two of these functional ingredients in foods. However, the combined effects of dietary fiber and WA on the postprandial hyperglycemia and also on chronic glucide and lipid metabolism are unknown. Here the simultaneous intake of these ingredients was examined using a rat model of type 2 diabetes mellitus.
MATERIALS AND METHODS
Approval and feeding conditions. All rats were maintained under standard conditions of 2362˚C and 55615% humidity with a 12 h/12 h light/dark cycle. The rats were individually housed in clean cages with free access to water and basal diet (CLEA rodent diet CE-2; CLEA Japan, Inc., Tokyo, Japan) ad libitum during the acclimation period. All the animal studies were performed at Gifu University and were approved by the Animal Care and Use Committee for Animal Experimentation of Gifu University (Acute study, approval number: 24-86; Chronic study, approval number: .
Bioactive ingredients. The dietary fiber mixture (DF) was provided by Miki Corporation (Osaka, Japan). The raw materials of DF were as follows: oat bran, chicory root extract, guar bean split-product, young barley leaves, oat fiber, konjac potato extract, green oat extract, and seaweed extracts. The total dietary fiber content of DF was 54.4%, which included 39.9% water-soluble dietary fiber, and 14.5% water-insoluble dietary fiber.
WA is a bioactive ingredient of food for FOSHU and provided by Miki Corporation. WA, which is a water-soluble protein fraction of wheat, is known to inhibit mammalian salivary and pancreatic amylases (8) .
Acute study. Animals and experimental design: The oral starch tolerance tests (OSTTs) were performed as a randomized, four-way, cross-over trial. Eight-week-old male Goto-Kakizaki (GK) rats (n512) were purchased from Japan SLC, Inc. (Shizuoka, Japan). After a 14-d period of acclimatization with basal diet, OSTTs were performed at four measurement points: 10, 11, 12, and 13 wk old. A wash-out period of 1 wk was maintained between each OSTT. Since there was no statistically sig-E-mail: kubochan@gifu-u.ac.jp nificant difference among the values of fasting blood glucose measured at these four times (p.0.05, Tukey's test), adoption of the randomized, four-way, cross-over trial was judged appropriate.
After 15 h of fasting, the rats received soluble starch solution [700 mg/kg body weight (bw)] with bioactive ingredients, DF (300 mg/kg bw), WA (300 mg/kg bw), or DF1WA (300 mg/kg bw1300 mg/kg bw). Blood from the tail vein was collected into capillary tubes containing lithium-heparin 0, 30, 60, 120, and 180 min after receiving the test solutions. Blood samples were centrifuged (15,000 3g for 15 min) to separate the plasma.
Blood glucose: The concentration of glucose in the plasma was measured using a commercial enzymatic assay kit (Glucose CII-Test Wako, Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Chronic study. Animals and diet: Five-wk-old male Zucker diabetic fatty (ZDF) rats (n524), as well as lean rats (n56) for use as the reference, were purchased from Charles River Laboratories Japan, Inc. (Yokohama, Japan). After a 7-d acclimatization period on the basal diet, six rats per group were maintained for 84 d on an experimental diet formulated on the basis of the AIN-93G diet for rodents (9) . DF was substituted for cornstarch and cellulose powder, and WA was substituted for milk casein (Table 1) . Food and water were available ad libitum.
Fasting blood glucose: Fasting blood glucose was measured 5, 10, and 12 wk after the start of the chronic study. After an overnight fast, the blood glucose measurement was performed using the method described above for the acute study.
Treatment of tissues: After 12 wk, the (18-wk-old) rats were sacrificed by cardiac puncture after an overnight fast. Liver, perirenal fat, and epididymal fat were resected and weighed immediately. Part of the liver was immediately stored at 280˚C until needed for analysis.
The remainder was immediately stored in the RNA stabilization solution RNAlater (Ambion, Austin, TX, USA), which preserved the RNA in the tissue before storage at 280˚C for total RNA extraction. Plasma was fractionated from a part of the blood by centrifugal separation.
Assay procedures: Total liver lipids were extracted by the method of Bligh and Dyer (10) . Briefly, appropriate volumes of chloroform and methanol (1 : 2) were added to the tissue (0.5 g) homogenized in 1 mL of distilled water in order to obtain a one-phase system consisting of CHCl3/CH3OH/H2O (1 : 2 : 0.8, v/v/v). After vigorous mixing, the appropriate volumes of chloroform and water were added to obtain a two-phase system CHCl3/ CH3OH/H2O at 1 : 1 : 0.9 ratios (v/v/v) followed by another vigorous mixing. Then, the mixture was centrifuged to allow the formation of the two liquid phases. The chloroform phase containing total lipids was removed and evaporated under nitrogen stream and lipid extract was reconstituted in 2 mL isopropanol. The levels of triglycerides and total cholesterol were measured by using commercial enzymatic assay kits (Wako Pure Chemical Industries, Ltd.), Triglyceride E-test Wako and Cholesterol E-test Wako, respectively.
Glycosylated hemoglobin (HbA1c) concentrations were determined with a high-performance liquid chromatography method performed using an HLC-723 GHbV automatic glycohemoglobin analyzer (Toso, Tokyo) equipped with a boronic acid column (11) . Commercial enzymatic assay kits (Wako Pure Chemical Industries, Ltd.) were used to measure the levels of glucose (Glucose CII-test Wako), triglycerides (TG; Triglyceride E-test Wako), total cholesterol (T-Cho; Cholesterol E-test Wako), high density lipoprotein cholesterol (HDL-C; HDL-Cholesterol E-test Wako), and nonesterified fatty acids (NEFA; NEFA C-test Wako) in the plasma.
Analysis of mRNA levels: Total RNA was extracted from liver samples using the mirVana TM PARIS TM kit (Life Technologies, Carlsbad, CA, USA) according to the man- ufacturer's instructions, before being stored at 280˚C. The extracted RNA was reverse-transcribed using a First Strand cDNA Synthesis kit for real-time RT-PCR and the PrimeScript TM RT reagent Kit (Perfect Real Time; Takara Bio Inc., Shiga, Japan) according to the manufacturer's instructions.
Primers for real-time PCR were designed from the published sequences of rat fatty acid synthase (Fasn), acetyl coenzyme A carboxylase alpha (Acaca), MLX interacting protein-like (Mlxipl), sterol regulatory element binding transcription factor 1 (Srebf1), 3-hydroxy-3-methylglutaryl coenzyme A reductase (Hmgcr), cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), acyl-CoA dehydrogenase, long chain (Acadl), acyl-CoA dehydrogenase, very long chain (Acadvl), carnitine palmitoyltransferase 1a (Cpt1a), acyl-coenzyme A oxidase 1 (Acox1), glucose-6-phosphatase (G6pc), phosphoenolpyruvate carboxykinase 1 (Pck1), peroxisome proliferator activate receptor alpha (Ppara), peroxisome proliferator activate receptor gamma (Pparg), tumor necrosis factor (Tnf), C-C motif chemokine ligand 2 (Ccl2), and 18S ribosomal RNA (Rn18s) cDNA (DDBJ/EMBL/GenBank). All primer sequences are shown in Table 2 .
Real-time RT-PCR was performed using the StepOne real time PCR system (Thermo Fisher Scientific, Waltham, MA) with a commercially available master mix (Fast SYBR ® Green Master Mix; Thermo Fisher Scientific) containing Taq DNA polymerase and SYBRGreen I dye. After the addition of the primers and template DNA to the master mix, DNA polymerase activation (95˚C for 20 s), 40 cycles of denaturation (95˚C for 3 s), and annealing/extension (60˚C for 30 s) were performed. Each mRNA level was expressed as the value relative to the levels of Rn18s mRNA.
Statistical analysis. All data were expressed as the mean6standard error (SE). Data were analyzed by a two-way ANOVA in order to investigate the combined effects of DF and WA. When an interaction (DF3WA) was detected to be statistically significant, differences among the groups were tested by Dunnett's multiple range test as a post hoc test.
RESULTS

Acute study
OSTTs. Blood glucose levels after soluble starch load were markedly elevated in GK rats, particularly in rats that were administered the vehicle control, and the glucose peak was observed at 60 min ( Fig. 1) . At 30 and 60 min during the OSTT, the blood glucose levels of both rats being loaded with DF and WA were lower than those of the rats being loaded with vehicle. The effects of each of these bioactive ingredients were confirmed as their main effect (Table 3) . Furthermore, at 60 min during the OSTT, the blood glucose levels of rats that were simultaneously administered DF and WA were lower than those of rats that were separately administered these bioactive ingredients. The suppressive effect of the blood glucose peak by the combination was confirmed as the interaction of DF and WA (Table 3) .
Chronic study
Food intake, body weight, and tissue weight. Food intake, initial body weight, and tissue weights were higher in the control group than in the lean group (Table 4) . The food intake tended to be low in the WA group and DF1WA group, relative to that of the control group, and the main effect of WA was detected. On the other hand, the liver weights were low in the DF group compared to that in the control group, and the main effect of the DF was detected. On the other hand, the perirenal fat weight (g/100 g bw) decreased in the WA and DF1WA groups from that in the control group, and the main effect of WA was detected.
Fasting plasma glucose level and HbA1c concentration. The fasting blood glucose and HbA1c levels were high in the control group relative to those of the lean group (Table 5 ). HbA1c levels tended to be low in the WA and DF1WA groups, relative to that in the control group, and the main effect of WA was observed.
Plasma and liver lipid levels. All the plasma lipid levels were higher in the control group than in the lean group (Table 6) . The plasma TG, T-Cho, HDL-C, and NEFA levels of the DF and DF1WA groups were lower than those of the control group, and the main effects of DF were detected, respectively.
The liver TG and T-Cho levels were higher in the control group than in the lean group, and those in rats fed the bioactive ingredients, particularly DF, were significantly lower than those in the control group. Therefore, the main effects of DF and an interaction were detected in the liver TG and T-Cho levels, respectively. Gene expression. The gene expression levels in the liver, except for those of the genes encoding Mlxipl and Pparg, were high in the control rats from those in the lean rats (Table 7) . The Srebf1 and G6pc mRNA expression levels were lower in the DF and DF1WA groups than in the control group, and the main effects of DF were detected, respectively. The Hmgcr and Tnf mRNA expression levels were high in the DF and DF1WA groups compared to those in the control group, and the main effects of DF were detected, respectively. On the other hand, the Cpt1a mRNA expression level was low in the WA and DF1WA groups compared to that in the control group, and the main effect of WA was detected. Pck1 mRNA expression level was significantly lowered in the DF and WA groups, but not in the DF1WA groups, from that in the control group, and an interaction of DF and WA was detected.
DISCUSSION
In this study, the combined effects of DF and WA against hyperglycemia and dyslipidemia were investigated in acute and chronic studies with type 2 diabetes mellitus rats.
In the acute OSTTs, an interaction was observed for the combined intake of DF and WA. The combined effect was thought to be due to each function of DF and WA as follows. Because the DF used for the OSTTs included 14.5% water-soluble dietary fiber, its ability to suppress hyperglycemia when administered alone (Fig. 1 ) was thought to be due to its ability to inhibit the diffusion of glucides through gel formation by the water-soluble dietary fiber (12) . On the other hand, it is clear that WA's ability to suppress hyperglycemia when administered alone (Fig. 1) is due to its ability to inhibit a-amylase activity, since there is an a-amylase inhibitor present in WA (13, 14) . In the acute study, the ability of DF to physically inhibit glucide digestion and the ability of WA to inhibit a-amylase activity were additive or partially synergistic and were found to suppress the steep hyperglycemia seen in the type 2 diabetes mellitus rats.
In the chronic ingestion study, the combination of DF and WA had no effect on the HbA1c levels or fasting blood glucose levels. However, WA showed a trend toward lowering the levels of HbA1c, which is an important index of long-term diabetic control (Table 5) . WA, which is rich in a-amylase inhibitor, is a bioactive ingredient of FOSHU for which a disease risk reduction is authorized in Japan.
Accordingly, WA was thought to show constant and partly suppressive effects for the severe diabetes mellitus ZDF rats. On the other hand, Scott et al. (15) reported that the effects of dietary fiber were not obtained in poorly controlled humans with more than 10% HbA1c. The HbA1c levels of the ZDF rats in this study were 10% or more. Also, in patients with poor glycemic control and more than 9.3% HbA1c, the contribution ratio of the suppressed postprandial blood glucose level for HbA1c is low; approximately 40% (16) . In other words, HbA1c shows a stronger relationship with fasting blood glucose level than with postprandial blood glucose (17, 18) . The Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe (DECODE) study demonstrated that cardiovascular mortality correlates with the peak glucose level within 2 h of glucose loading, and the risk of death among diabetic patients cannot be discriminated using only fasting blood sugar data (19) . Even if the combined effect of DF and WA was not clear in a chronicity study, if the inhibition of postprandial hyperglycemia is important in diabetes prevention and cardiovascular mortality, the combined effect on postprandial hyperglycemia observed in the acute experiment (Fig. 1) will contribute at least to diabetes prevention.
The combined effect observed upon chronic intake of DF and WA was the improvement of liver lipids (Table  6 ). In comparison with the ZDF rat and the lean rat, though the final body weight was almost the same, the difference of the liver weight was double ( Table 4 ), and that of the TG weight per total liver resulted in a fourfold increase in the ZDF rat (Table 6 ). Nevertheless, it is thought that the ZDF rat in this study did not develop a remarkable fatty liver. In ZDF rats, fatty liver was not found until 15 wk of age, but it was observed after 20 wk of age (20) . Therefore, at 18 wk of age when the anatomy was examined in this study, the lipid accumulation in the liver of the ZDF rat was mild and it was regarded that the fatty liver was in progress. The initial step of fatty acid biosynthesis is the conversion of acetyl-CoA to malonyl-CoA. Expression of the RNAs encoding Acaca and Fasn, which are enzymes in the fatty acid biosynthetic pathway, is promoted by Srebf1 (21, 22) . However, the expression of Acaca and Fasn, which is controlled synchronously by Srebf1, showed a lowering trend because Srebf1 gene expression tended to decrease in the livers of DF-fed rats. On the other hand, the intake of WA suppressed expression of the Cpt1a gene and showed a trend toward lowering the levels of liver lipids. That is to say, in the WA intake group, the expression of Cpt1a, which catalyzes the rate-determining step of b-oxidation, was thought to decrease along with the decrease in the levels of liver lipids, which are the substrate of b-oxidation. The depression of the Cpt1a gene expression in the liver of the WA intake group caused a depression trend of plasma TG concentrations and, through a systemic circulation, might be related with the depression of the perirenal fat weight per body weight. Hmgcr (23) , which is a rate-limiting key enzyme of the cholesterol biosynthetic pathway, and strongly controls cholesterol synthesis, but its transcription is also controlled by the intracellular cholesterol content; thus, this enzyme maintains internal cholesterol homeostasis (24) . Because intracellular cholesterol content decreased conspicuously in the livers of DF-fed rats, Hmgcr gene expression was thought to be promoted in the DF intake groups. Expression of the gene encoding G6pc tended to be low in the DF group relative to that in the control group. The result suggests that the inhibition of gluconeogenesis and glucose secretion from the liver might be associated with the antidiabetic efficacy of DF. The expression of Pck1, which promotes gluconeogenesis, tended to be suppressed in the liver of DF-or WA-fed rats, but the reason for the offset by the combined intake is not clear. On the other hand, a trend toward increased expression of the Tnf gene in the liver was recognized in the DF intake groups. Because Tnf induces insulin resistance, a future survey concerning its relationship with the intake of DF is warranted.
The changes in plasma lipid concentrations (TG, T-Cho, and HDL-C) were associated with those of liver lipid contents (Table 6) . A conspicuous improvement in liver lipid levels from those in the WA group was observed in the DF group (Table 6) . In most cases, diets with increased DF improve hyperlipidemia (25) . On the other hand, when refined DF and foods high in DF content are ingested, their effects vary according to the kind of dietary fiber and the food (25) . Generally, the lipidlowering effect is strong in the water-soluble and high viscous dietary fiber, but the effect of water-insoluble dietary fiber is weak or ineffective. Guar gum, pectin, oats and legumes have a particularly remarkable effect. The oat bran-derived b-glucan was the primary component in the DF used in this study. We speculate that the mechanism by which DF ingestion reduces blood cholesterol levels is as follows (26) . First, the dietary fiber increases fecal bile acid excretion. The effect may not be caused by promoted catabolism of cholesterol in the liver. In fact, expression of the gene encoding Cyp7a1, which is the rate-limiting enzyme of cholesterol catabolism in the liver, did not change (Table 7) . In this study, however, anatomy was examined after fasting overnight in consideration of the disappearance of diet-derived chylomicrons. Thus, the possibility that fasting affected the mRNA level cannot be entirely ruled out. On the other hand, dietary fiber is thought to adsorb bile acids. As a result, micellar formation is suppressed and thus, absorption of various lipids in the small intestine is suppressed. This effect is strong especially in highly viscous, water-soluble dietary fiber. The main component of the water-soluble dietary fiber found in the cell wall of barley, oats, and wheat is b-glucan (27) . The plasma cholesterol-reducing effect of this substance has been identified in many studies in humans and experimental animals (28) (29) (30) (31) .
Chicory is the primary raw material for the production of inulin, which is present in this plant at 15-20% wet weight (32, 33) . Inulin is thought to inhibit hyperglycemia by promoting the secretion of pancreatic insulin. In other words, inulin inhibits hyperglycemia as follows (34) (35) (36) . Inulin is assimilated by intestinal flora. The short chain fatty acids produced by these flora stimulate enteroendocrine cells, which, in turn, secrete glucagonlike peptide-1, which promotes pancreatic insulin secretion. Guar gum is composed primarily of galactomannan, a polysaccharide included in the guar seed. Guar gum is a water-soluble polysaccharide known to reduce blood glucose and/or cholesterol levels (37) (38) (39) . Glucomannan, a high-viscosity soluble dietary fiber, has been shown to improve glycemic control and peripheral insulin sensitivity in type 2 diabetes (40) . Konjacmannan, a natural constituent of konjac root, is a highly viscous water-soluble fiber that has been shown to reduce fasting and postprandial glycemia, as well as cardiovascular risk factors (41) . Alginate has been reported to have high viscosity and gel organization potency and shown to suppress hyperglycemia, and also to promote fecal bile acid and cholesterol excretion (42) . Thus, the improvements in lipid metabolism seen with DF in this study are thought to be the comprehensive effects of these watersoluble dietary fibers.
In conclusion, this study demonstrated that the combined intake of DF and WA improved the postprandial hyperglycemia and the chronic lipid metabolism disorders in an additive or partial synergistic manner in rat models of type 2 diabetes mellitus.
